Risk factors for cardiovascular disease during the period 1985-1995 in Goteborg, Sweden. The GOT-MONICA project

Journal of Internal Medicine

Volumn 242, Issue 3, 1997, Pages 199-211

  Wilhelmsen, L ^a   Johansson, S ^a,b   Rosengren, A ^a   Wallin, I ^a   Dotevall, A ^a   Lappas, G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Cardiovascular risk factors; Population studies and time trends

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY WEIGHT; CORONARY RISK; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0030775556     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00163.x     Document Type: Article

References (25)

1. Uemura K, Pisa Z. Recent trends in cardiovascular disease mortality in 27 industrialized countries. World Health Statistics Quarterly 1985; 38: 142-62.
2. The Principal Investigators of the MONICA Project. WHO MONICA Project: geographic variation in mortality from cardiovascular diseases - baseline data on selected population characteristics and cardiovascular mortality. World Health Statistics Quarterly 1987; 40: 171-84.
3. Farchi G. Spontaneous changes in risk factors and prediction of coronary heart disease. Preventive Medicine 1983; 12: 37-9.
4. Jackson R, Beaglehole R. Trends in dietary fat and cigarette smoking and the decline in coronary heart disease in New Zealand. Int J Epidemiol 1987; 16: 377-82.
5. Ueshima H et al. Declining mortality from ischaemic heart disease and changes in coronary risk factors in Japan, 1956-1980. Am J Epidemiol 1987; 125: 62-72.
6. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br Med J 1994; 309: 23-7.
7. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease) - a major international collaboration. J Clin Epidemiol 1988; 41: 105-14.
8. Rosengren A, Wilhelmsen L. Physical activity protects against coronary death and from deaths from all causes in middle aged men. Evidence from a 20 year follow-up of the Primary Prevention Study in Göteborg. Ann Epidemiol 1900; : (in press)-.
9. Rosengren A, Tibblin G, Wilhelmsen L. Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol 1991; 68: 1171-5.
10. Wilhelmsen L, Johansson S, Ulvenstam G, Welin L, Rosengren A, Eriksson H et al. CHD in Sweden: mortality, incidence and risk factors over 20 years in Gothenburg. Intern J Epidemiol 1989; 18 (Suppl. 1): S101-8.
11. Ribacke M, Tibblin G, Rosengren A, Eriksson H. Is hypertension changing? Blood pressure development in cohorts of 50-year-old men between 1963 and 1993. Blood Pressure 1996; 5: 134-8.
12. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II. Analysis of observational data within populations. Br Med J 1991; 302: 815-8.
13. Berglund G, Wilhelmsen L. Factors related to blood pressure in a general population sample of Swedish men. Acta Med Scand 1975; 198: 291-8.
14. Welin C, Rosengren A, Wedel H, Wilhelmsen L. Myocardial infarction in relation to work, family, and life events. Cardiovascular Risk Factors 1995; 5: 30-38.
15. Wilhelmsen L, Rosengren A, Johansson S, Lappas G. Coronary heart disease attack rate, incidence and mortality 1975-1994 in Göteborg, Sweden. Eur Heart J 1997; 18: 572-8.
16. Welin L, Wilhelmsen L, Svärdsudd K, Larsson B, Tibblin G. Increasing mortality from ischemic heart disease among males in Sweden. Cardiology 1985; 72: 75-80.
17. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K et al. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 1986; 7: 279-88.
18. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease. A prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 30: 1248-51.
19. Johansson S, Bondjers G, Fager G, Johansson B, Olofsson S-O, Wedin A et al. Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Arteriosclerosis 1988; 8: 742-9.
20. Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rybo E. Triglycerides - main lipid risk factor for cardiovascular disease in women?. Acta Med Scand 1985; 217: 481-9.
21. Wilhelmsen L, Wedel H, Tibblin G. Multivariate analyses of risk factors for coronary heart disease. Circulation 1973; 48: 950-58.
22. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
23. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. for the West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-7.
24. Wilhelmsen L, Ljungberg S, Wedel H, Werkö L. A comparison between participants and non-participants in a primary preventive trial. J Chron Dis 1976; 29: 331-9.
25. Rosengren A, Wilhelmsen L, Berglund G, Elmfeldt D. Nonparticipants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand 1987; 221: 243-51.